Co-administration of AYUSH 64 as an adjunct to standard of care in mild and moderate COVID-19: A randomized, controlled, multicentric clinical trial

OBJECTIVE: Evaluate the efficacy of AYUSH 64, a standard polyherbal Ayurvedic drug in COVID-19. METHODS: During the first pandemic wave, 140 consenting and eligible hospitalized adult participants with mild-moderate symptomatic disease (specific standard RT-PCR assay positive) were selected as per a...

Descripción completa

Detalles Bibliográficos
Autores principales: Chopra, Arvind, Tillu, Girish, Chuadhary, Kuldeep, Reddy, Govind, Srivastava, Alok, Lakdawala, Muffazal, Gode, Dilip, Reddy, Himanshu, Tamboli, Sanjay, Saluja, Manjit, Sarmukaddam, Sanjeev, Gundeti, Manohar, Raut, Ashwini Kumar, Rao, B. C. S., Yadav, Babita, Srikanth, Narayanam, Patwardhan, Bhushan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019690/
https://www.ncbi.nlm.nih.gov/pubmed/36928877
http://dx.doi.org/10.1371/journal.pone.0282688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019690/
https://www.ncbi.nlm.nih.gov/pubmed/36928877
http://dx.doi.org/10.1371/journal.pone.0282688

Ejemplares similares